admin

Digital pharmacy GoodRx is now helping patients do more than just price shop for prescription drugs, co-founder and co-CEO Doug Hirsch told CNBC’s Jim Cramer on Friday. It’s going directly into the world of medical services by launching GoodRx Care, which allows people to see a board-certified physician for a number of conditions, starting at
0 Comments
A new “Test-the-Waters” rule by the Securities and Exchange Commission could help stave off disappointing public market debuts — like those felt by Peloton and SmileDirectClub in recent weeks. The rule, announced Thursday, comes on the heels of a string of lackluster IPOs, and is intended to help companies gauge investor interest before officially going
0 Comments
Recent highly publicized flops by supposedly disruptive companies could be painting an unpleasant picture ahead for innovation, at least in how it’s viewed in the financial markets. Investors have turned thumbs-down on high-profile companies including WeWork, Uber and Tesla. Industries including marijuana, vaping and bitcoin all have seen big price drops following a spate of
0 Comments
The 45th Annual Notre Dame Tax & Estate Planning Institute in South Bend, IN brings together some of the top estate planners from around the country to lecture at a two day conference. This is the first in a series of articles elaborating on some of the many planning nuggets gleaned from the conference that
0 Comments
A interview with billionaire debt investor and founder of Oaktree Capital Management, Howard Marks. In this interview, Howard discusses why value investors have struggled in recent times and what points of the cycle provide the best investment opportunities. Howard also talks about his early career and gives advice to those just starting out in asset
0 Comments
CNBC’s Jim Cramer reacts to the Trump administration’s move to consider stopping U.S. investors from investing into China’s businesses and debriefs the 2019 class of IPOs. The “Mad Money” host makes recommendations for investors who are worried about the future of the American health care system. He holds an interview with the CEO of CNBC
0 Comments
An interview and Q&A with billionaire and founder of the quantitative hedge fund Renaissance Technologies, James Simons. In this interview, James discusses his quantitative approach to investing and how this has evolved over his career. James also talks about fundamental trading and how his management style has helped make Renaissance Technologies so successful. Like if
0 Comments